IncFact
Company Profiles: Revenue, Growth, Competition

Path Ex Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Path Ex

Access the complete profile.

Path Ex Fast Facts

RevenueLess than $1 million    See Exact Annual Revenue
Employees1 - 10Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address111 10th Ave S
Ste 105
Nashville, TN 37203

Note: Revenues for privately held companies are statistical evaluations.


Path Ex's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Path Ex is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Path Ex Annual Revenue and Growth Rate

Path Ex Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Less than $1 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Path Ex's revenues are gauged from an analysis of company filings.



Path Ex's Income Statement (based on Industry Averages)

Path Ex P&L$ Millions
Revenue (Sales) Path Ex Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Investor Activity

Path Ex has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
May 5, 2017 2 100%$0 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Path Ex is developing and marketing. Path Ex doesn't have any recent trademark applications, indicating Path Ex is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
PATH EX
Medical devices for the diagnosis and treatment of systemic infections and sepsis and in particular a fluidic device for purifying blood by removing materials from blood
06/12/2017

See all trademarks and details in the Full Report.


Market Share of Path Ex's Largest Competitors

A competitive analysis shows these companies are in the same general field as Path Ex, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Path Ex. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
REVANCE THERAPEUTICSNashville, TN100 
AUTISM EDUCATION & THERAPY CENTERNashville, TN10 
APPLIED HEALTH ANALYTICSNashville, TN4 
MUZOLOGYNashville, TN1 
APPELLO PHARMACEUTICALSNashville, TN0 
PATH EXNashville, TN0 




Future Competition: Path Ex's Fastest Growing Competitors

These companies are in the same general field as Path Ex and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Path Ex Competitors